| Fri, Aug 28, 2009 | | • | Is There Life After a 714% Return?
at Motley Fool (Fri, Aug 28)
| | Thu, Aug 27, 2009 | | • | IMMUNOMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Aug 27)
| | • | Immunomedics Announces Fiscal 2009 Results
GlobeNewswire (Thu, Aug 27)
| | • | Top Takes From RealMoney
at TheStreet.com (Thu, Aug 27)
| | • | Feeling Bullish About Dell
at Forbes.com (Thu, Aug 27)
| | • | Immunomedics rallies on lupus drug study
at MarketWatch (Thu, Aug 27)
| | • | UCB and Immunomedics Announce Positive Results for Epratuzumab Phase IIb Study in Systemic Lupus Erythematosus (SLE)
GlobeNewswire (Thu, Aug 27)
| | Fri, Aug 14, 2009 | | • | Immunomedics Announces FDA Allowance of Investigational New Drug Application for Milatuzumab-Doxorubicin Conjugate
GlobeNewswire (Fri, Aug 14)
| | Fri, Aug 7, 2009 | | • | IMMUNOMEDICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Fri, Aug 7)
| | Fri, Jul 24, 2009 | | • | Immunomedics Partners With Alexis Biotech to Develop Targeted Vaccines in Cancer and AIDS
GlobeNewswire (Fri, Jul 24)
| | Wed, Jul 22, 2009 | | • | 10 Stocks Shaking the Market
at Motley Fool (Wed, Jul 22)
| | Tue, Jul 21, 2009 | | • | Immunomedics Announces U.S. Patent for a Facile Method of Fluorine-18 Labeling of Proteins and Peptides
GlobeNewswire (Tue, Jul 21)
| | Fri, Jul 17, 2009 | | • | Biotech Stock Mailbag: Immunomedics
at TheStreet.com (Fri, Jul 17)
| | Wed, Jul 15, 2009 | | • | Immunomedics Announces U.S. Patents Awarded for Bispecific Antibody Technologies
GlobeNewswire (Wed, Jul 15)
| | Tue, Jul 14, 2009 | | • | [$$] Dabbling in Some Longs
at RealMoney by TheStreet.com (Tue, Jul 14)
| | Wed, Jun 17, 2009 | | • | Immunomedics Reports Improved Efficacy With Combination Veltuzumab and Pretargeted Anti-CD20 Radioimmunotherapy in Lymphoma Model
GlobeNewswire (Wed, Jun 17)
| | Tue, Jun 16, 2009 | | • | IMMUNOMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Tue, Jun 16)
| | • | Immunomedics Reports New Antibody for Pretargeted Imaging and Therapy of Colorectal Cancer
GlobeNewswire (Tue, Jun 16)
| | Mon, Jun 15, 2009 | | • | Immunomedics Reports Improved F-18 Labeling of Peptides for PET Imaging of Tumors
GlobeNewswire (Mon, Jun 15)
| | • | Immunomedics Reports Updated Phase II Results With Radiolabeled Epratuzumab in Non-Hodgkin's Lymphoma
GlobeNewswire (Mon, Jun 15)
| | Fri, Jun 12, 2009 | | • | 5 Cold Stocks Heating Up
at Motley Fool (Fri, Jun 12)
| | Mon, Jun 8, 2009 | | • | Immunomedics to Present At the Society of Nuclear Medicine 56th Annual Meeting
GlobeNewswire (Mon, Jun 8)
| | Fri, Jun 5, 2009 | | • | Immunomedics Reports Updated Results of Low-Dose Veltuzumab for Immune Thrombocytopenic Purpura
GlobeNewswire (Fri, Jun 5)
| | Mon, Jun 1, 2009 | | • | Top Takes From RealMoney
at TheStreet.com (Mon, Jun 1)
| | • | Immunomedics Reports First Efficacy Results of Subcutaneous Humanized Anti-CD20 Antibody Therapy of Lymphoma With Veltuzumab
GlobeNewswire (Mon, Jun 1)
|
Add IMMU News to My Yahoo!:
 
| |
|
0.25% Nasdaq 
0.54%
Headlines
